Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 20778 | 446 | 47.5 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 442 | 3 | DERMATOLOGY//VITILIGO//DERMATOL | 26460 |
| 3766 | 2 | MINOCYCLINE//BLACK THYROID//COL 3 | 1000 |
| 20778 | 1 | MINOCYCLINE//NEUROSURGNEURO OPTOSIS//1 DIPHENYL 2 PICRYLHYDROZYL RADICAL | 446 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | MINOCYCLINE | authKW | 3809138 | 53% | 23% | 238 |
| 2 | NEUROSURGNEURO OPTOSIS | address | 73022 | 1% | 27% | 4 |
| 3 | 1 DIPHENYL 2 PICRYLHYDROZYL RADICAL | authKW | 68464 | 0% | 100% | 1 |
| 4 | 6 ODHA | authKW | 68464 | 0% | 100% | 1 |
| 5 | 6 OHDA PARKINSON MODEL | authKW | 68464 | 0% | 100% | 1 |
| 6 | A BETABETA OLIGOMERS | authKW | 68464 | 0% | 100% | 1 |
| 7 | ANESTHESIA INDUCED COGNITIVE IMPAIRMENT | authKW | 68464 | 0% | 100% | 1 |
| 8 | ANTI MYELIN OLIGODENDROCYTE PROTEIN ANTIBODIES | authKW | 68464 | 0% | 100% | 1 |
| 9 | BIOACT SUBST OURCES UNILIZAT CHINESE | address | 68464 | 0% | 100% | 1 |
| 10 | BLOOD CYTOKINES SCREENING | authKW | 68464 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Neurosciences | 3306 | 50% | 0% | 223 |
| 2 | Clinical Neurology | 631 | 17% | 0% | 78 |
| 3 | Pharmacology & Pharmacy | 415 | 20% | 0% | 88 |
| 4 | Psychiatry | 206 | 9% | 0% | 39 |
| 5 | Medicine, Research & Experimental | 77 | 6% | 0% | 27 |
| 6 | Immunology | 50 | 7% | 0% | 31 |
| 7 | Peripheral Vascular Diseases | 29 | 3% | 0% | 14 |
| 8 | Cell Biology | 20 | 6% | 0% | 25 |
| 9 | Behavioral Sciences | 15 | 2% | 0% | 8 |
| 10 | Ophthalmology | 15 | 2% | 0% | 10 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | NEUROSURGNEURO OPTOSIS | 73022 | 1% | 27% | 4 |
| 2 | BIOACT SUBST OURCES UNILIZAT CHINESE | 68464 | 0% | 100% | 1 |
| 3 | CLARA CHRISTIE MOUSE GENOM MODELLING HUMAN | 68464 | 0% | 100% | 1 |
| 4 | CREAT INOTIAT ALZHEIMERS DEMENTIA | 68464 | 0% | 100% | 1 |
| 5 | DEP COMPARAT BIOSCI | 68464 | 0% | 100% | 1 |
| 6 | EMMY NOETHER EPR GRP | 68464 | 0% | 100% | 1 |
| 7 | EXPT NEUROPROTECT NEURODEGENERAT | 68464 | 0% | 100% | 1 |
| 8 | GASTROINTESTINAL VAGAL AFFERENT GRP | 68464 | 0% | 100% | 1 |
| 9 | HOSP QUANZHOU AFFILIATED 1 | 68464 | 0% | 100% | 1 |
| 10 | ICM THER EUT EXPT NEURODEGENE CENCE CRICM6 | 68464 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | NEUROIMMUNOMODULATION | 1710 | 0% | 3% | 1 |
| 2 | GLIA | 1494 | 2% | 0% | 9 |
| 3 | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 1119 | 2% | 0% | 9 |
| 4 | JOURNAL OF NEUROINFLAMMATION | 1014 | 1% | 0% | 5 |
| 5 | JOURNAL OF NEUROIMMUNOLOGY | 1002 | 2% | 0% | 10 |
| 6 | NEUROBIOLOGY OF DISEASE | 905 | 2% | 0% | 7 |
| 7 | EXPERIMENTAL NEUROLOGY | 875 | 2% | 0% | 11 |
| 8 | CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS | 692 | 1% | 0% | 3 |
| 9 | NEUROTOXICITY RESEARCH | 623 | 1% | 0% | 3 |
| 10 | NEURAL REGENERATION RESEARCH | 591 | 1% | 0% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | GARRIDO-MESA, N , ZARZUELO, A , GALVEZ, J , (2013) WHAT IS BEHIND THE NON-ANTIBIOTIC PROPERTIES OF MINOCYCLINE?.PHARMACOLOGICAL RESEARCH. VOL. 67. ISSUE 1. P. 18 -30 | 73 | 43% | 33 |
| 2 | PLANE, JM , SHEN, Y , PLEASURE, DE , DENG, WB , (2010) PROSPECTS FOR MINOCYCLINE NEUROPROTECTION.ARCHIVES OF NEUROLOGY. VOL. 67. ISSUE 12. P. 1442-1448 | 31 | 86% | 95 |
| 3 | GARRIDO-MESA, N , ZARZUELO, A , GALVEZ, J , (2013) MINOCYCLINE: FAR BEYOND AN ANTIBIOTIC.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 169. ISSUE 2. P. 337-352 | 56 | 36% | 91 |
| 4 | KIM, HS , SUH, YH , (2009) MINOCYCLINE AND NEURODEGENERATIVE DISEASES.BEHAVIOURAL BRAIN RESEARCH. VOL. 196. ISSUE 2. P. 168 -179 | 38 | 48% | 206 |
| 5 | ORSUCCI, D , CALSOLARO, V , MANCUSO, M , SICILIANO, G , (2009) NEUROPROTECTIVE EFFECTS OF TETRACYCLINES: MOLECULAR TARGETS, ANIMAL MODELS AND HUMAN DISEASE.CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. VOL. 8. ISSUE 3. P. 222-231 | 43 | 54% | 24 |
| 6 | FAGAN, SC , CRONIC, LE , HESS, DC , (2011) MINOCYCLINE DEVELOPMENT FOR ACUTE ISCHEMIC STROKE.TRANSLATIONAL STROKE RESEARCH. VOL. 2. ISSUE 2. P. 202-208 | 27 | 59% | 35 |
| 7 | YONG, VW , WELLS, J , GIULIANI, F , CASHA, S , POWER, C , METZ, LM , (2004) THE PROMISE OF MINOCYCLINE IN NEUROLOGY.LANCET NEUROLOGY. VOL. 3. ISSUE 12. P. 744-751 | 29 | 53% | 256 |
| 8 | LI, CY , YUAN, KX , SCHLUESENER, H , (2013) IMPACT OF MINOCYCLINE ON NEURODEGENERATIVE DISEASES IN RODENTS: A META-ANALYSIS.REVIEWS IN THE NEUROSCIENCES. VOL. 24. ISSUE 5. P. 553-562 | 28 | 54% | 10 |
| 9 | XUE, MZ , MIKLIAEVA, EI , CASHA, S , ZYGUN, D , DEMCHUK, A , YONG, VW , (2010) IMPROVING OUTCOMES OF NEUROPROTECTION BY MINOCYCLINE GUIDES FROM CELL CULTURE AND INTRACEREBRAL HEMORRHAGE IN MICE.AMERICAN JOURNAL OF PATHOLOGY. VOL. 176. ISSUE 3. P. 1193-1202 | 27 | 56% | 24 |
| 10 | SOCZYNSKA, JK , MANSUR, RB , BRIETZKE, E , SWARDFAGER, W , KENNEDY, SH , WOLDEYOHANNES, HO , POWELL, AM , MANIERKA, MS , MCINTYRE, RS , (2012) NOVEL THERAPEUTIC TARGETS IN DEPRESSION: MINOCYCLINE AS A CANDIDATE TREATMENT.BEHAVIOURAL BRAIN RESEARCH. VOL. 235. ISSUE 2. P. 302 -317 | 57 | 23% | 38 |
Classes with closest relation at Level 1 |